Solid Biosciences LLC (SLDB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $723.24M
Last updated: Nov 17, 2026 at 4:10 PM ET
Solid Biosciences LLC (SLDB) Statistics
Solid Biosciences LLC (SLDB) has a market cap of $723.24M and an enterprise value of $597.26M. Its share count is up 59.96% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 17.42% below the market cap, as cash exceeds debt.
| Market Cap | $723.24M |
|---|---|
| Enterprise Value | $597.26M |
| Latest price (Nov 17, 2026) | $6.23 |
Key Dates
The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 4, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 4, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 46.93% over 52 weeks and trades 11.63% below its 50-day average.
| Beta (1Y) | 2.10 |
|---|---|
| 52-Week Change | +46.93% |
| 1-Month Change | +5.24% |
| 3-Month Change | -36.04% |
| 6-Month Change | +2.47% |
| 5-Year Change | -79.63% |
| Total Return (1Y) | +46.93% |
| Total Return (3Y CAGR) | +34.32% |
| Total Return (5Y CAGR) | -27.14% |
| Return vs SPY (1Y) | +27.81% |
| Max Drawdown (1Y) | -50.99% |
| Max Drawdown (3Y) | -82.92% |
| Sharpe Ratio (1Y) | 0.44 |
| Correlation with SPY (1Y) | 0.38 |
| 50-Day Average | $7.05 |
| 200-Day Average | $7.68 |
| 52-Week Range | $4.40 to $11.45 |
| RSI (14 Days) | 43.9 |
| Average Volume (20 Days) | 1.26M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 11.99x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 11.99x |
|---|---|
| Quick Ratio | 11.99x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -62.92% over the last 12 months, against a 5-year average of -67.78%.
| Return on Equity (ROE) | -62.92% |
|---|---|
| Return on Assets (ROA) | -55.21% |
| ROE (5Y Average) | -67.78% |
| ROA (5Y Average) | -52.68% |
| ROIC (5Y Average) | -80.94% |
Scores
SLDB has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$467.00K |
| Operating Income | -$221.75M |
| Pretax Income | -$215.27M |
| Net Income | -$215.27M |
| Reported EPS (TTM) | -$1.79 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 87.74% of the $389.90M in total assets.
| Cash and Equivalents | $125.97M |
|---|---|
| Total Debt | $0 |
| Net Cash | $125.97M |
| Net Cash Per Share | $0.83 |
| Working Capital | $334.74M |
| Shareholder Equity | $342.11M |
| Book Value Per Share | $2.27 |
| Total Assets | $389.90M |
| Total Liabilities | $47.79M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.38M of capital spending, operating cash flow left -$200.30M of free cash flow.
| Operating Cash Flow | -$198.92M |
|---|---|
| Capital Expenditures | $1.38M |
| Free Cash Flow | -$200.30M |
| FCF Per Share | -$1.87 |
| Depreciation and Amortization | $5.86M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -33.97% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -33.97% |
Dividends and Yields
SLDB does not pay a dividend. Its free cash flow yield is -21.29%.
| FCF Yield | -21.29% |
|---|---|
| Buyback Yield | -32.73% |
| Shareholder Yield | -32.73% |
Stock Splits
The last split was a 1-for-15 reverse split on Oct 28, 2022.
| Last Split Date | Oct 28, 2022 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SLDB
What is SLDB's market cap?
Solid Biosciences LLC has a market cap of $723.24M. Its enterprise value, which adds debt and subtracts cash, is $597.26M.
How many shares of SLDB are outstanding?
Solid Biosciences LLC has 151.03M shares outstanding. The count is up 59.96% from a year earlier.
Does SLDB pay a dividend?
No. Solid Biosciences LLC does not pay a dividend.
How much debt does SLDB have?
Solid Biosciences LLC has $0 of total debt and $125.97M of cash and equivalents, a net cash position of $125.97M.
SLDB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors